CNMDCONMED Corporation

$50.47

$32.1152 weeks$55.60

Price

$50.47-5.1%1Y

1M+22%1Y-5.1%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Average

6/10

Value66

Quality77

Momentum28

Growth32

Strongest Quality, weakest Momentum · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company’s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. The Company’s 3,900 employees distribute its products worldwide from three primary manufacturing locations.

In the company’s own words · 10-K filed Feb 17, 2026 · SEC EDGAR

P/E (TTM)33.4

Market Cap$1.04B

1Y Return-5.1%

5Y Return-61%

Business segments

Q2 2026 · $152.3M

The company’s own SEC segment disclosure.

United States$51.7M34%
EMEA$40.3M26%
Asia Pacific$36.6M24%
Americasexcludingthe United States$23.8M16%

CONMED Corporation (CNMD) reported revenue of $373M in Q4 2025 (quarter ended December 31, 2025), up 7.9% from the same quarter a year earlier. That came with a gross margin of 58% and net income of $17M (4.5% of revenue). For the full year FY2025, revenue was $1.37B (+5.2% year on year) and net income $47M. Its largest region in 2026-Q2 was United States at $52M, 34% of the disclosed total, just ahead of EMEA at 26%.

Raw charts

11 series · TTM

As reported to the SEC, without any scoring.

Medical Devices

The closest names by size in the same industry

Compare peers

ALMR+13%

Alamar Biosciences, Inc.

HAE+6.5%

Haemonetics Corporation

BIO+6.5%

Bio-Rad Laboratories, Inc.

TNDM+4.9%

Tandem Diabetes Care, Inc.